Cross Icon

TRC Plus for Hereditary Angioedema

Cross Icon
Caring doctor puts patient at ease

Total cost and care for Hereditary Angioedema (HAE)

HAE is a rare, often hereditary swelling condition that affects 6,000 patients in the U.S. Due to many variables, HAE can be unpredictable for plan sponsors, making it difficult to budget costs and ensure patients are on the right combination of treatments.

TRC Plus is redefining care for HAE patients

Ensure the best care for patients and better manage overall HAE costs with capabilities such as:
HAE Grand Rounds

is a collaborative clinical approach through our HAE TRC to reviewing patient cases, allowing our pharmacists to offer recommendations to prescribers that are accepted across specialty disciplines more than 50% of the time.1

1. Accredo clinical studies compiled from 2013-2023.

injection shot
Accredo OneAdherenceTM

which tracks medication usage through a wifi-enabled syringe disposal device and includes patient dose reminder texts and follow ups from Accredo nurses.

HAE therapy discounts

across the HAE therapy class with an average monthly savings of $10,000.

Custom reporting

on plan-specific spend estimates across all HAE therapies and a self-service dashboard to review therapy utilization.

Cross Icon
Cross Icon
Achieve higher predictability and transparency for your HAE population today
Cross Icon
Cross Icon
Explore more